334 related articles for article (PubMed ID: 23297127)
1. High PD-1 expression and suppressed cytokine signaling distinguish T cells infiltrating follicular lymphoma tumors from peripheral T cells.
Myklebust JH; Irish JM; Brody J; Czerwinski DK; Houot R; Kohrt HE; Timmerman J; Said J; Green MR; Delabie J; Kolstad A; Alizadeh AA; Levy R
Blood; 2013 Feb; 121(8):1367-76. PubMed ID: 23297127
[TBL] [Abstract][Full Text] [Related]
2. Stromal PD-L1-Positive Regulatory T cells and PD-1-Positive CD8-Positive T cells Define the Response of Different Subsets of Non-Small Cell Lung Cancer to PD-1/PD-L1 Blockade Immunotherapy.
Wu SP; Liao RQ; Tu HY; Wang WJ; Dong ZY; Huang SM; Guo WB; Gou LY; Sun HW; Zhang Q; Xie Z; Yan LX; Su J; Yang JJ; Zhong WZ; Zhang XC; Wu YL
J Thorac Oncol; 2018 Apr; 13(4):521-532. PubMed ID: 29269008
[TBL] [Abstract][Full Text] [Related]
3. Follicular lymphoma cells induce changes in T-cell gene expression and function: potential impact on survival and risk of transformation.
Kiaii S; Clear AJ; Ramsay AG; Davies D; Sangaralingam A; Lee A; Calaminici M; Neuberg DS; Gribben JG
J Clin Oncol; 2013 Jul; 31(21):2654-61. PubMed ID: 23775959
[TBL] [Abstract][Full Text] [Related]
4. Functional Heterogeneity of CD4
Oja AE; Piet B; van der Zwan D; Blaauwgeers H; Mensink M; de Kivit S; Borst J; Nolte MA; van Lier RAW; Stark R; Hombrink P
Front Immunol; 2018; 9():2654. PubMed ID: 30505306
[TBL] [Abstract][Full Text] [Related]
5. Follicular lymphoma cell niche: identification of a preeminent IL-4-dependent T(FH)-B cell axis.
Pangault C; Amé-Thomas P; Ruminy P; Rossille D; Caron G; Baia M; De Vos J; Roussel M; Monvoisin C; Lamy T; Tilly H; Gaulard P; Tarte K; Fest T
Leukemia; 2010 Dec; 24(12):2080-9. PubMed ID: 20944673
[TBL] [Abstract][Full Text] [Related]
6. Selective targeting of Toll-like receptors and OX40 inhibit regulatory T-cell function in follicular lymphoma.
Voo KS; Foglietta M; Percivalle E; Chu F; Nattamai D; Harline M; Lee ST; Bover L; Lin HY; Baladandayuthapani V; Delgado D; Luong A; Davis RE; Kwak LW; Liu YJ; Neelapu SS
Int J Cancer; 2014 Dec; 135(12):2834-46. PubMed ID: 24771328
[TBL] [Abstract][Full Text] [Related]
7. T Cells Expressing Checkpoint Receptor TIGIT Are Enriched in Follicular Lymphoma Tumors and Characterized by Reversible Suppression of T-cell Receptor Signaling.
Josefsson SE; Huse K; Kolstad A; Beiske K; Pende D; Steen CB; Inderberg EM; Lingjærde OC; Østenstad B; Smeland EB; Levy R; Irish JM; Myklebust JH
Clin Cancer Res; 2018 Feb; 24(4):870-881. PubMed ID: 29217528
[No Abstract] [Full Text] [Related]
8. TGFβ1-Mediated SMAD3 Enhances PD-1 Expression on Antigen-Specific T Cells in Cancer.
Park BV; Freeman ZT; Ghasemzadeh A; Chattergoon MA; Rutebemberwa A; Steigner J; Winter ME; Huynh TV; Sebald SM; Lee SJ; Pan F; Pardoll DM; Cox AL
Cancer Discov; 2016 Dec; 6(12):1366-1381. PubMed ID: 27683557
[TBL] [Abstract][Full Text] [Related]
9. Mass Cytometry Analysis Reveals that Specific Intratumoral CD4
Yang ZZ; Kim HJ; Villasboas JC; Price-Troska T; Jalali S; Wu H; Luchtel RA; Polley MC; Novak AJ; Ansell SM
Cell Rep; 2019 Feb; 26(8):2178-2193.e3. PubMed ID: 30784598
[TBL] [Abstract][Full Text] [Related]
10. Immune-Checkpoint Blockade Opposes CD8
Pfannenstiel LW; Diaz-Montero CM; Tian YF; Scharpf J; Ko JS; Gastman BR
Cancer Immunol Res; 2019 Mar; 7(3):510-525. PubMed ID: 30728151
[TBL] [Abstract][Full Text] [Related]
11. Oncolytic herpes simplex virus HF10 (canerpaturev) promotes accumulation of CD8
Eissa IR; Mukoyama N; Abdelmoneim M; Naoe Y; Matsumura S; Bustos-Villalobos I; Ichinose T; Miyajima N; Morimoto D; Tanaka M; Fujimoto Y; Sone M; Kodera Y; Kasuya H
Int J Cancer; 2021 Jul; 149(1):214-227. PubMed ID: 33687756
[TBL] [Abstract][Full Text] [Related]
12. Prognostic value of tissue-infiltrating immune cells in tumor microenvironment of follicular lymphoma: A meta-analysis.
Xie M; Jiang Q; Zhao S; Zhao J; Ye X; Qian W
Int Immunopharmacol; 2020 Aug; 85():106684. PubMed ID: 32540726
[TBL] [Abstract][Full Text] [Related]
13. IL-12 upregulates TIM-3 expression and induces T cell exhaustion in patients with follicular B cell non-Hodgkin lymphoma.
Yang ZZ; Grote DM; Ziesmer SC; Niki T; Hirashima M; Novak AJ; Witzig TE; Ansell SM
J Clin Invest; 2012 Apr; 122(4):1271-82. PubMed ID: 22426209
[TBL] [Abstract][Full Text] [Related]
14. [CD45RO⁺ Memory T Lymphocytes As A Candidate Marker for Non-small Cell Lung Cancer].
Tan Q; Li H; Yu M; Tang X; Tan J; Zhang S; Wang J
Zhongguo Fei Ai Za Zhi; 2021 Apr; 24(4):254-264. PubMed ID: 33910273
[TBL] [Abstract][Full Text] [Related]
15. Epithelial ovarian cancer is infiltrated by activated effector T cells co-expressing CD39, PD-1, TIM-3, CD137 and interacting with cancer cells and myeloid cells.
Tassi E; Bergamini A; Wignall J; Sant'Angelo M; Brunetto E; Balestrieri C; Redegalli M; Potenza A; Abbati D; Manfredi F; Cangi MG; Magliacane G; Scalisi F; Ruggiero E; Maffia MC; Trippitelli F; Rabaiotti E; Cioffi R; Bocciolone L; Candotti G; Candiani M; Taccagni G; Schultes B; Doglioni C; Mangili G; Bonini C
Front Immunol; 2023; 14():1212444. PubMed ID: 37868997
[TBL] [Abstract][Full Text] [Related]
16. PD-1 expression defines two distinct T-cell sub-populations in follicular lymphoma that differentially impact patient survival.
Yang ZZ; Grote DM; Ziesmer SC; Xiu B; Novak AJ; Ansell SM
Blood Cancer J; 2015 Feb; 5(2):e281. PubMed ID: 25700246
[TBL] [Abstract][Full Text] [Related]
17. Characterization of intratumoral follicular helper T cells in follicular lymphoma: role in the survival of malignant B cells.
Amé-Thomas P; Le Priol J; Yssel H; Caron G; Pangault C; Jean R; Martin N; Marafioti T; Gaulard P; Lamy T; Fest T; Semana G; Tarte K
Leukemia; 2012 May; 26(5):1053-63. PubMed ID: 22015774
[TBL] [Abstract][Full Text] [Related]
18. PD-1 Expression in Head and Neck Squamous Cell Carcinomas Derives Primarily from Functionally Anergic CD4
Mattox AK; Lee J; Westra WH; Pierce RH; Ghossein R; Faquin WC; Diefenbach TJ; Morris LG; Lin DT; Wirth LJ; Lefranc-Torres A; Ishida E; Chakravarty PD; Johnson L; Zeng YC; Chen H; Poznansky MC; Iyengar NM; Pai SI
Cancer Res; 2017 Nov; 77(22):6365-6374. PubMed ID: 28947422
[TBL] [Abstract][Full Text] [Related]
19. Tumour-immune microenvironment in duodenal-type follicular lymphoma.
Inoue H; Rai S; Tanaka H; Espinoza JL; Watatani Y; Kumode T; Serizawa K; Nakayama S; Taniguchi Y; Morita Y; Tatsumi Y; Ashida T; Matsumura I
Br J Haematol; 2020 Oct; 191(2):243-252. PubMed ID: 32383789
[TBL] [Abstract][Full Text] [Related]
20. Expression of programmed death-1 (CD279) in primary cutaneous B-cell lymphomas with correlation to lymphoma entities and biological behaviour.
Mitteldorf C; Bieri M; Wey N; Kerl K; Kamarachev J; Pfaltz M; Kutzner H; Roncador G; Tomasini D; Kempf W
Br J Dermatol; 2013 Dec; 169(6):1212-8. PubMed ID: 23937075
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]